Evidence map›Paper›PMID 37560966›Full record

ArticleThe Journal of international medical research2023

Evaluation of splenic infarction ratio and platelet increase ratio after partial splenic artery embolization.

Junji Ueda, Yasuhiro Mamada, Nobuhiko Taniai, Masato Yoshioka, Akira Matsushita, Satoshi Mizutani, Youichi Kawano, Tetsuya Shimizu, Tomohiro Kanda, Hideyuki Takata and 7 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Clinical management of thrombocytopenia in cirrhosis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Junji UedaDepartment of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-5-1, Sendagi, Bunkyo-ku, Tokyo, Japan.ORCID 0000-0001-6189-0762
Yasuhiro MamadaDepartment of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-5-1, Sendagi, Bunkyo-ku, Tokyo, Japan.
Nobuhiko TaniaiDepartment of Gastrointestinal Surgery, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi, Nakahara-ku, Kawasaki city, Kanagawa, Japan.
Masato YoshiokaDepartment of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-5-1, Sendagi, Bunkyo-ku, Tokyo, Japan.
Akira MatsushitaDepartment of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-5-1, Sendagi, Bunkyo-ku, Tokyo, Japan.
Satoshi MizutaniDepartment of Gastrointestinal Surgery, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi, Nakahara-ku, Kawasaki city, Kanagawa, Japan.
Youichi KawanoDepartment of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-5-1, Sendagi, Bunkyo-ku, Tokyo, Japan.
Tetsuya ShimizuDepartment of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-5-1, Sendagi, Bunkyo-ku, Tokyo, Japan.ORCID 0000-0002-5877-9526
Tomohiro KandaDepartment of Surgery, Nippon Medical School Tama Nagayama Hospital, 1-7-1, Nagayama, Tama-city, Tokyo, Japan.
Hideyuki TakataDepartment of Gastrointestinal Surgery, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi, Nakahara-ku, Kawasaki city, Kanagawa, Japan.
Hiroyasu FurukiDepartment of Surgery, Nippon Medical School Tama Nagayama Hospital, 1-7-1, Nagayama, Tama-city, Tokyo, Japan.
Yuto AokiDepartment of Gastrointestinal Surgery, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari Inzai, Chiba, Japan.
Manpei KawashimaDepartment of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-5-1, Sendagi, Bunkyo-ku, Tokyo, Japan.
Toshiyuki IrieDepartment of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-5-1, Sendagi, Bunkyo-ku, Tokyo, Japan.
Takashi OhnoDepartment of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-5-1, Sendagi, Bunkyo-ku, Tokyo, Japan.
Takahiro HarunaDepartment of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-5-1, Sendagi, Bunkyo-ku, Tokyo, Japan.
Hiroshi YoshidaDepartment of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-5-1, Sendagi, Bunkyo-ku, Tokyo, Japan.
Nippon Medical School · JPNippon Medical School Musashi Kosugi Hospital · JPChiba Hokusou Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe spleen is part of the lymphatic system and is one of the least understood organs of the human body. It is involved in the production of blood cells and helps filter the blood, remove old blood cells, and fight infection. Partial splenic artery embolization (PSE) is widely used to treat pancytopenia and portal hypertension. The efficacy of PSE for improving thrombocytopenia has been well demonstrated. In this study, we evaluated the splenic infarction ratio and platelet increase ratio after PSE.

methodsForty-five consecutive patients underwent PSE from January 2014 to August 2022. We retrospectively evaluated the splenic infarction volume and ratio after PSE and analyzed the relationship between the splenic infarction ratio and platelet increase ratio after PSE.

resultsThe platelet increase ratio was correlated with the splenic infarction ratio after PSE. The cutoff value for the splenic infarction ratio with a two-fold platelet increase was 63.0%.

conclusionWe suggest performance of PSE in patients with a splenic infarction ratio of 63% to double the expected platelet count.

Indexed as

HypersplenismSplenic InfarctionHumansRetrospective StudiesSplenic Arteryhypersplenismpartial splenic artery embolizationplatelet increase ratioSpleensplenic infarction ratiothrombocytopenia

Identifiers

PMID37560966
PMCPMC10416656
OpenAlexW4385715688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.